+91-8510955039

PUBLICATIONS

 
  1. Luvhengo, T.E., Miya, T.V., Basera, A., Fadebi, O., Mehrotra, R., Dlamini, Z. (2024). The Microbiome: A New Frontier in Overcoming Drug Resistance in Breast Cancer. In: Dlamini, Z. (eds) Overcoming Breast Cancer Therapy Resistance. Springer, Cham. https://doi.org/10.1007/978-3-031-52860-6_11 
  2. Kathryn Coyle, Prashant Kumar Singh, Ravi Kaushik, Rumana Huque, Zohaib Khan, Ravi Mehrotra, Kamran Siddiqi, Subhash Pokhrel, The Lifetime Health and Economic Burden of Smokeless Tobacco use in Bangladesh, India, and Pakistan: Results From ASTRAMOD, Nicotine & Tobacco Research, 2024;, ntae067, https://doi.org/10.1093/ntr/ntae067 
  3.  Kocarnik JM, Compton K, Dean FE,….,Mehrotra R, Fitzmaurice C, Murray CJL, Force LM (2022) Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2022;8(3):420-444. doi:10.1001/jamaoncol.2021.6987  PMID: 34967848
  4. Mehrotra R, Yadav K (2022) Cervical Cancer: Formulation and Implementation of Govt of India Guidelines. Ind Jour Gyn Oncol PMID: 34977333
  5. Verma G, Aggarwal N,Tyagi A, Vishnoi K, Jadli M, Singh T, Goel, Pandey D, Sharma A, Agarwal A, Sarkar U, Doval DC, Sharma S, Mehrotra R, Singh SM, Bharti AC. (2022) Detection of Human Papillomavirus Infection in Oral Cancers reported at Dental Facility: Assessing the Utility of FFPE tissues. Medical Oncology PMID: 34792663

  6. Mehrotra R, Yadav K, Cree I, Fields A, Vielh P (2022) The importance of cytopathological diagnosis in early cancer diagnosis in resource-constrained countries. Jour Global Oncol. PMID: 35213215
  7. Livingstone-Banks J, Siddiqui F, Croucher R, Mehrotra R, Readshaw A, Vidyasagaran A, Siddiqi K. (2022) Interventions for smokeless tobacco use cessation. Cochrane Database Systematic Reviewshttps://doi.org/10.1002/14651858.CD015314.
  8. Mehrotra R, Yadav K. (2022) Breast Cancer in India: The Current Scenario and the Challenges for the Future. World Jour Clin OncolFP7191
  9. Mehrotra R et al. (2022) Alcohol and Cancer: Evidence to Action. Indian J Med ResIJMR 4037_20 

  10. GBD Group, Kocarnik JM, Mehrotra R et al. (2021) Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life Years for 29 Cancer Groups from 2010 to 2019: A Systematic Analysis of Cancer Burden Globally, Nationally, and by Socio-demographic Index for the Global Burden of Disease Study 2019. JAMA Oncology PMID: 3496784

  11. Bairi KE, Haynes H, Mehrotra R et al. for International Immuno-Oncology Biomarker Working Group. (2021) The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.NPJ Breast Cancer PMID: 34853355
  12. GBD Group, Mehrotra R et al. (2021) GBD 2019 Adolescent and Young Adult Cancer Collaborators. (2022) The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the GBD study 2019. Lancet Oncology PMID: 34871551
  13. Yadav K, Ginsberg O, Basu P, Mehrotra R. (2021) Telemedicine and cancer care in LMICs during SARS-COV-2 pandemic. Jour Glob OncolPMID: 34860567 
  14. Nethan S, Cherian MN, Brain E, Ganguli A, Tullu FT, Musolino N, Hariprasad R, Sullivan R, Mehrotra R. (2021) Cancer in the olderIndian population: understanding the current context in an emerging economy. Jour Geriatric Oncol PMID: 34776381 
  15. Hull R, Lolas G, Makrogkikas S, Jensen LD, Syrigos KN, Evangelo G, Padayachy L, Egbor C, Mehrotra R, Makhafola TJ, Oyomno M, Dlamini Z. (2021) Microbiomics in collusion with the Nervous System in Carcinogenesis: diagnosis, pathogenesis and treatment. MicroorganismsPMID: 34683450 
  16. Gupta AK, Mehrotra R. (2021) Safety concerns for tobacco-free products containing synthetic nicotine. Nicotine Tob ResPMID: 33836086

  17. Haque R, Al Azdi Z, Sheikh A, Ahluwalia JS, Mishu MP, Mehrotra R, Ahmed N, Bauld L, Huq SM, Alam MS, Siddiqi F, Choudhury SR, Siddiqi K (2021) Policy priorities for strengthening smokeless tobacco control in Bangladesh: a mixed-method analysis. Tobacco Induced DisPMID: 34707471
  18. Gupta AK, Mehrotra R. (2021) Increasing use of flavoured tobacco products amongst youth. Ind Jour TuberculosisPMID: 34538383
  19. India State-level Disease Burden Neurological Diseases Collaboration, Mehrotra R. (2021) The burden of neurological disorders across the states of India: the Global Burden of Disease Study 1990-2019. Lancet Global healthPMID: 34273302
  20. Nethan ST, Lakshmi K, Ralhan, R, Mishra D, Rath GK, Pandey RM, Mehrotra R,Srivastava A. (2021) Assessment of the prevalence and relationship of tobacco use and associated oral lesions in an urban population of New Delhi: a cross-sectional study. Indian J Surg https://doi.org/10.1007/s12262-021-03055-y
  21. Mehrotra R, Nethan ST, Yadav K (2021) Socio-cultural tailoring of the comprehensive geriatric assessment tool for low – and middle-income countries: The need of the hour.Cancer Research Stat Treatment  DOI: 10.4103/crst.crst_64_21
  22. Nethan ST, Kumar V, Sharma S, Sinha DN, Hariprasad R, Mehrotra R, Srivastava A (2021) Tobacco use among urban-slum dwellers attending a clinical setting in Noida (India): a cross-sectional study.eCancermedicalscience PMID: 34158834

  23. Shridhar K, Aggarwal A; Rawal I, Gupta R, Masih S, Mehrotra R, Gillespie RW, Dhillon PK, Michaud DS; Prabhakaran D; Goodman M (2021) Exploring the Role of Selected Oral Bacterial Pathogens in Oral Carcinogenesis: A Population-based Case-control Study in India. PLoS 1PMID: 33914825
  24. McDonald J, Rao R, Gibbons M, Janardhanan R, Jaswal S, Mehrotra R, Pandey M, Radhakrishnan V, Ramakant P, Verma N, Terry MB. (2021) Symposium Report: Breast Cancer in India – Trends, Environmental Exposures and Clinical Implications.  Cancer Causes ControlPMID: 33909208
  25. SarinA, Chaturvedi P, Mehrotra R, Ranjan P, Seth S, Janardhanan R. (2021). Descriptive investigation of Government events and public interest analysis using google trends between Pictorial Health Warnings policy implementation and Electronic Nicotine Delivery ban in India. Medico-legal Update 21; 2
  26. Basu P, Tripathi R, Mehrotra R, Ray K, Srivastava A, Srivastava A. (2021) Role of Integrative medicine in the continuum of care of breast cancer patients in the Indian context. Cancer Causes ControlPMID: 33528692 
  27. Bondhopadhyay B, Sisodiya S, Nazir S, Khan A, Tanwar P, Afroze D, Singh Neha, Rasool I, Agrawal U, Rath GK, Mehrotra R, Hussain S. (2021) The dynamics of Promyelocytic Leukemia (PML) and retinoblastoma (RB1) genes in breast cancer progression. MetaGene doi.org/10.1016/j.mgene.2021.100852
  28. Gupta AK, Nethan ST, Mehrotra R. (2021) Tobacco use a well-recognized cause of severe COVID-19 disease. Resp MedPMID: 33253975
  29. Marima R, Hull R, Mathabe K, Setlai B, Batra J,  Sartor O,  Mehrotra R, Dlamini Z. (2021) Prostate cancer racial, socioeconomic, geographic disparities: targeting the genomic landscape and splicing events in search for diagnostic, prognostic and therapeutic targets. Am J Cancer ResPMID: 33948343
  30. Gupta AK, Mehrotra R. (2021) Alarmingly high levels of nicotine and carcinogenic nitrosamines in smokeless tobacco products sold worldwide.Nicotine Tob Res PMID: 32951041
  31. Pandey A, India State-Level Disease Burden Initiative Air Pollution Collaborators, Mehrotra R. (2021) Health and economic impact of air pollution in the states of India: the Global Burden of Disease Study 2019. Lancet Planetary HealthPMID: 33357500

  32. Gupta AK, Mehrotra R. (2021)High Levels of sugars, Humectants and their Toxic By-Products present In Diverse Tobacco Products. Nicotine Tob Res   PMID: 33438748
  33. Babu R, Dhanasekaran K, Mehrotra R, Hariprasad R. (2021) Leveraging Technology for Nation-wide Training of Healthcare Professionals in Cancer Screening in India: A Methods Article. J Cancer Ed 1-7 PMID: 32130665